BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25503115)

  • 61. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
    He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X
    Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
    Camp ER; Yang A; Gray MJ; Fan F; Hamilton SR; Evans DB; Hooper AT; Pereira DS; Hicklin DJ; Ellis LM
    Cancer; 2007 Mar; 109(6):1030-9. PubMed ID: 17311308
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular prognostic markers in pancreatic cancer.
    Coppola D
    Cancer Control; 2000; 7(5):421-7. PubMed ID: 11000611
    [TBL] [Abstract][Full Text] [Related]  

  • 67. NR4A1, 2, 3--an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis.
    Li QX; Ke N; Sundaram R; Wong-Staal F
    Histol Histopathol; 2006 May; 21(5):533-40. PubMed ID: 16493583
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Insulin-like growth factor binding protein (IGFBP) signalling.
    Ricort JM
    Growth Horm IGF Res; 2004 Aug; 14(4):277-86. PubMed ID: 15231296
    [No Abstract]   [Full Text] [Related]  

  • 69. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
    Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
    Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular markers of tumors.
    Kushlinsky NE; Gershtein ES; Ovchinnikova LK; Digaeva MA
    Bull Exp Biol Med; 2009 Aug; 148(2):230-7. PubMed ID: 20027336
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumor receptor imaging.
    Mankoff DA; Link JM; Linden HM; Sundararajan L; Krohn KA
    J Nucl Med; 2008 Jun; 49 Suppl 2():149S-63S. PubMed ID: 18523071
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The molecular epidemiology of growth signal transduction proteins.
    Brandt-Rauf PW; De Vivo I; Marion MJ; Hemminki K
    J Occup Environ Med; 1995 Jan; 37(1):77-83. PubMed ID: 7620946
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nuclear receptors in pancreatic tumor cells.
    Damaskos C; Garmpis N; Karatzas T; Kostakis ID; Nikolidakis L; Kostakis A; Kouraklis G
    Anticancer Res; 2014 Dec; 34(12):6897-911. PubMed ID: 25503115
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Growth factors and their receptors in pancreatic cancer.
    Ozawa F; Friess H; Tempia-Caliera A; Kleeff J; Büchler MW
    Teratog Carcinog Mutagen; 2001; 21(1):27-44. PubMed ID: 11135319
    [TBL] [Abstract][Full Text] [Related]  

  • 75. SIBLINGs and SPARC families: their emerging roles in pancreatic cancer.
    Kaleağasıoğlu F; Berger MR
    World J Gastroenterol; 2014 Oct; 20(40):14747-59. PubMed ID: 25356037
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.